Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARFIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FICD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPG21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDX10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSHR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
OXLD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OAZ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRELID2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNFT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC31A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on